UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

February 4, 2014

 

 

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32431   90-0199783

(State or other jurisdiction of

incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

100 Potrero Avenue

San Francisco, CA 94103-4813

(Address of principal executive offices) (Zip Code)

(415) 558-0200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

5.07(a) and (b)

At the Dolby Laboratories, Inc. (the “Company”) 2014 Annual Meeting of Stockholders (the “Annual Meeting”), held on February 4, 2014, at the Company’s principal executive offices located at 100 Potrero Avenue, San Francisco, California, 94103, the Company’s stockholders:

 

  1. Elected nine directors to serve until the 2015 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified;

 

  2. Approved an advisory vote to approve the compensation of the Company’s named executive officers; and

 

  3. Ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 26, 2014.

Each share of the Company’s Class A Common Stock is entitled to one vote, and each share of the Company’s Class B Common Stock is entitled to ten votes, on all matters submitted to a vote of stockholders at the Annual Meeting. The Class A Common Stock and Class B Common Stock voted together as a single class on all matters submitted to a vote of stockholders at the Annual Meeting. At the Annual Meeting, the holders of Class A Common Stock and Class B Common Stock voted as follows:

Proposal 1 – Election of directors:

 

Director

   Votes For      Votes Withheld      Broker Non-Votes  

Peter Gotcher

     577,271,707         1,107,117         4,495,953   

Micheline Chau

     577,992,979         385,845         4,495,953   

David Dolby

     576,021,268         2,357,556         4,495,953   

Nicholas Donatiello, Jr.

     577,991,383         387,441         4,495,953   

Bill Jasper

     577,708,986         669,838         4,495,953   

Sanford Robertson

     577,685,830         692,994         4,495,953   

Roger Siboni

     577,848,510         530,314         4,495,953   

Avadis Tevanian, Jr.

     577,991,696         387,128         4,495,953   

Kevin Yeaman

     578,062,477         316,347         4,495,953   

All director nominees were duly elected.

Proposal 2 – Approval of an advisory vote to approve the compensation of the Company’s named executive officers:

 

Votes For

  

Votes Against

  

Abstentions

  

Broker Non-Votes

558,967,350

   19,367,831    43,643    4,495,953

Proposal 2 was approved.

Proposal 3 – Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 26, 2014:

 

Votes For

  

Votes Against

  

Abstentions

581,589,175

   907,453    378,149

Proposal 3 was approved.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  DOLBY LABORATORIES, INC.
By:  

/s/ Andy Sherman

      Andy Sherman
      Executive Vice President, General Counsel
          and Secretary

Date: February 10, 2014